🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

8 recruiting trials

for Diarrhea-predominant Irritable Bowel Syndrome

Efficacy of Rifaximin With NAC in IBS-D NCT06727422Phase 21 site📍 Los Angeles Mark Pimentel, MD · Tests: rifaximin 66mg + N-acetylcysteine 560mg three times daily, RNIB21 containing rifaximin 132mg + N-acetylcysteine 560mg t… Evaluation of the Efficacy and Safety of Gelsectan in the Treatment of Diarrhea-predominant Irritable Bowel Syndrome NCT07000383NA1 site📍 Ho Chi Minh City University Medical Center Ho Chi Minh City (UMC) · Tests: Gelsectan, Antispasmodic Agent Effect of Ebastine in Patients With Diarrhea Predominant Irritable Bowel Syndrome NCT07114055Phase 2, Phase 31 site📍 Dhaka Md. Hazrat Ali · Tests: ebastine, Placebo Study on the Effectiveness and Mechanism of Tong-Xie-Yao-Fang in Treating Diarrhea-predominant Irritable Bowel Syndrome NCT06737666Phase 11 site📍 Beijing Xiyuan Hospital of China Academy of Chinese Medical Sciences · Tests: Tong-Xie-Yao-Fang Repeated Transcranial Magnetic Stimulation for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Clinical Trial NCT07581756NA1 site📍 Suzhou The First Affiliated Hospital of Soochow University · Tests: rTMS group, sham device Saccharomyces Boulardii CNCM I-745 in Irritable Bowel Syndrome NCT07168434Phase 310 sites📍 Braga📍 Lisbon📍 Barcelona Biocodex · Tests: Saccharomyces Boulardii 250 MG, Placebo 250 mg Gelsectan® in the Treatment of Patients With Diarrhoea-predominant Irritable Bowel Syndrome NCT06681012NA12 sites📍 Leuven📍 Bobigny📍 Rouen Devintec Sagl · Tests: Gelsectan®, Placebo Efficacy of Repeated Transcranial Magnetic Stimulation Combined With a Live Probiotic Tablet (Combined Bifidobacterium, Lactobacillus, Enterococcus and Bacillus Cereus Tablets, Live) in Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) NCT06960369Phase 11 site📍 Suzhou The First Affiliated Hospital of Soochow University · Tests: rTMS combined with Live Probiotic tablet, rTMS combined placebo, shamrTMS combined with Live Probiotic tablet, shamrTMS…
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy